𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Synergistic growth inhibition by acyclic retinoid and phosphatidylinositol 3-kinase inhibitor in human hepatoma cells

✍ Scribed by Baba, Atsushi; Shimizu, Masahito; Ohno, Tomohiko; Shirakami, Yohei; Kubota, Masaya; Kochi, Takahiro; Terakura, Daishi; Tsurumi, Hisashi; Moriwaki, Hisataka

Book ID
121534581
Publisher
BioMed Central
Year
2013
Tongue
English
Weight
599 KB
Volume
13
Category
Article
ISSN
1471-2407

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Synergistic interaction between 17-AAG a
Synergistic interaction between 17-AAG and phosphatidylinositol 3-kinase inhibition in human malignant glioma cells
✍ Daniel R. Premkumar; Beth Arnold; Esther P. Jane; Ian F. Pollack πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 425 KB

## Abstract The phosphatidylinositol 3′‐kinase (PI3K)/Akt pathway is often constitutively activated in malignant glioma cells, in many cases as a result of mutation of phosphatase and tensin homologue deleted on chromosome ten (PTEN), an endogenous inhibitor of Akt, which renders tumor cells resist

Inhibition of phosphatidylinositol 3-kin
Inhibition of phosphatidylinositol 3-kinase signaling negates the growth advantage imparted by a mutant epidermal growth factor receptor on human glioblastoma cells
✍ Manuela Klingler-Hoffmann; Patricia Bukczynska; Tony Tiganis πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 French βš– 599 KB

## Abstract In __de novo__ glioblastoma multiforme, loss of the tumour suppressor protein PTEN can coincide with the expression of a naturally occurring mutant epidermal growth factor receptor known as Ξ”EGFR. Ξ”EGFR signals constitutively via the phosphatidylinositol 3‐kinase (PI3K)/protein kinase A